BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9791425)

  • 41. Depression during therapy with interferon alpha--how long should an antidepressant treatment last?
    Nickel T; Sonntag A; Backmund M; Pollmächer T
    Pharmacopsychiatry; 2005 Mar; 38(2):102-4. PubMed ID: 15744637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mirtazapine for the treatment of interferon-induced psychopathology.
    Russo S; Boon JC; Korf J; Haagsma EB
    Gen Hosp Psychiatry; 2003; 25(6):497. PubMed ID: 14706418
    [No Abstract]   [Full Text] [Related]  

  • 43. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
    Dinan TG
    J Clin Psychiatry; 1996; 57 Suppl 4():14-8. PubMed ID: 8636061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 45. [A combination effect of mianserin (Tolvon) and tricyclic antidepressive agents. Improved antidepressive therapy].
    Medhus A; Heskestad S; Thue JF
    Tidsskr Nor Laegeforen; 1990 Nov; 110(27):3527-8. PubMed ID: 2256091
    [No Abstract]   [Full Text] [Related]  

  • 46. [Mianserin: pharmacology and clinical aspects of an effective antidepressive agents].
    Demling J
    Fortschr Med; 1993 Nov; 111(31):497-500. PubMed ID: 8276338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Care of the sexually active depressed patient.
    Hirschfeld RM
    J Clin Psychiatry; 1999; 60 Suppl 17():32-5; discussion 46-8. PubMed ID: 10446740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Panic attacks during discontinuation of mirtazepine.
    Klesmer J; Sarcevic A; Fomari V
    Can J Psychiatry; 2000 Aug; 45(6):570-1. PubMed ID: 10986577
    [No Abstract]   [Full Text] [Related]  

  • 49. No influence of dialysis on mirtazapine - a case report.
    Schlotterbeck PM; Vehren T; Milenovic S; Hiemke C; Kircher T; Leube D
    Pharmacopsychiatry; 2008 Nov; 41(6):259-60. PubMed ID: 19067265
    [No Abstract]   [Full Text] [Related]  

  • 50. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Rapid treatment effect. An effective antidepressant dissolves on the tongue].
    MMW Fortschr Med; 2002 Aug; 144(33-34):53. PubMed ID: 12380147
    [No Abstract]   [Full Text] [Related]  

  • 52. Mirtazepine for MDMA-induced depression.
    Fetter JC
    Am J Addict; 2005; 14(3):300-1. PubMed ID: 16019980
    [No Abstract]   [Full Text] [Related]  

  • 53. Neurotransmitters in depression: noradrenaline and serotonin and their interactions.
    Leonard BE
    J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():1S. PubMed ID: 9090572
    [No Abstract]   [Full Text] [Related]  

  • 54. Mirtazapine-associated hyponatremia in an elderly patient.
    Famularo G; Gasbarrone L; De Virgilio A; Minisola G
    Ann Pharmacother; 2009 Jun; 43(6):1144-5. PubMed ID: 19435965
    [No Abstract]   [Full Text] [Related]  

  • 55. Mirtazapine: other indications.
    Falkai P
    J Clin Psychiatry; 1999; 60 Suppl 17():36-40; discussion 46-8. PubMed ID: 10446741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mirtazapine-induced hepatocellular-type liver injury.
    Kang SG; Yoon BM; Park YM
    Ann Pharmacother; 2011 Jun; 45(6):825-6. PubMed ID: 21666084
    [No Abstract]   [Full Text] [Related]  

  • 57. Massive weight gain and hostility force mirtazapine stoppage.
    Abraham G
    Can J Psychiatry; 2002 Aug; 47(6):582. PubMed ID: 12211888
    [No Abstract]   [Full Text] [Related]  

  • 58. [Mirtazapin and gynecomastia-galactorrhea].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2005 Feb; 132(2):195. PubMed ID: 15798581
    [No Abstract]   [Full Text] [Related]  

  • 59. Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
    Kang RH; Wong ML; Choi MJ; Paik JW; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1317-21. PubMed ID: 17618721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of mirtazapine in a patient with chronic pain.
    Brannon GE; Stone KD
    J Pain Symptom Manage; 1999 Nov; 18(5):382-5. PubMed ID: 10584463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.